We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$34.9B
1-Year Est. Return
18.88%
This Fund
S&P 500
This Quarter
Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
(+5.5%)
Cap. Flow
+$20.5M
Cap. Flow
% of AUM
0.18%
Top 10 Holdings %
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$47.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$38.9M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
+$24.1M |
| 4 |
Netflix
NFLX
|
+$21.5M |
| 5 |
Waste Management
WM
|
+$21.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$45.3M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
+$33.2M |
| 3 |
Danaher
DHR
|
+$28.3M |
| 4 |
FLTX
Fleetmatics Group PLC
FLTX
|
+$25.2M |
| 5 |
Healthcare Services Group
HCSG
|
+$24.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.99% |
| 2 | Technology | 15.43% |
| 3 | Financials | 11.87% |
| 4 | Industrials | 11.27% |
| 5 | Consumer Discretionary | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
226
DELISTED
Unilever NV New York Registry Shares
UN
| $9.18M | 0.08% |
199,087
+23,764
| +14% | +$1.1M |
|
|
AMJ
227
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $9.15M | 0.08% |
290,413
+8,861
| +3% | +$279K |
|
228
iShares Russell 1000 Growth ETF
IWF
$127B
| $9.06M | 0.08% |
347,884
-30,752
| -8% | -$800K |
|
229
Williams-Sonoma
WSM
$29.3B
| $8.84M | 0.08% |
346,208
-26,166
| -7% | -$684K |
|
230
Invesco QQQ Trust
QQQ
$485B
| $8.78M | 0.08% |
73,930
+3,069
| +4% | +$354K |
|
231
Ligand Pharmaceuticals
LGND
$6.03B
| $8.72M | 0.08% |
136,989
+27,948
| +26% | +$2.05M |
|
|
WPZ
232
DELISTED
Williams Partners L.P.
WPZ
| $8.67M | 0.08% |
233,148
-1,087
| -0.5% | -$40K |
|
233
RTX Corp
RTX
$294B
| $8.38M | 0.07% |
131,058
+1,237
| +1% | +$82K |
|
234
Independence Realty Trust
IRT
$4.02B
| $8.38M | 0.07% |
930,717
+50,572
| +6% | +$471K |
|
235
Kornit Digital
KRNT
$787M
| $8.29M | 0.07% |
884,336
-169,363
| -16% | -$1.71M |
|
236
TE Connectivity
TEL
$62.9B
| $8.18M | 0.07% |
127,059
-2,684
| -2% | -$164K |
|
237
Exelon
EXC
$47.2B
| $8.02M | 0.07% |
337,568
-687,942
| -67% | -$17.3M |
|
238
iShares Russell 1000 Value ETF
IWD
$83.4B
| $8.01M | 0.07% |
75,828
+4,230
| +6% | +$446K |
|
239
Microchip Technology
MCHP
$43.8B
| $8M | 0.07% |
257,402
+518
| +0.2% | +$15.1K |
|
240
Trimble
TRMB
$13.9B
| $7.92M | 0.07% |
277,191
-457,515
| -62% | -$12.2M |
|
241
Sherwin-Williams
SHW
$87.8B
| $7.82M | 0.07% |
84,756
+5,001
| +6% | +$485K |
|
242
Citigroup
C
$230B
| $7.71M | 0.07% |
163,158
-118,156
| -42% | -$5.37M |
|
243
BP
BP
$109B
| $7.62M | 0.07% |
257,714
-434,981
| -63% | -$12.6M |
|
244
Air Products & Chemicals
APD
$65.6B
| $7.59M | 0.07% |
54,584
-1,423
| -3% | -$197K |
|
245
iShares Select Dividend ETF
DVY
$23.8B
| $7.49M | 0.07% |
87,382
-893
| -1% | -$77.1K |
|
246
Biogen
BIIB
$30.8B
| $7.43M | 0.07% |
23,740
+198
| +0.8% | +$58.6K |
|
|
INFO
247
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $7.25M | 0.06% |
+193,156
| New | +$6.9M |
|
|
BSFT
248
DELISTED
BroadSoft, Inc.
BSFT
| $7.22M | 0.06% |
155,088
+4,615
| +3% | +$206K |
|
249
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $7.19M | 0.06% |
82,373
+11,399
| +16% | +$980K |
|
|
XEC
250
DELISTED
CIMAREX ENERGY CO
XEC
| $7.13M | 0.06% |
53,037
-3,759
| -7% | -$472K |
|
Similar funds
SAM
VIA
William Blair & Company's Q3 2016 Portfolio in Review
As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
- William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
- William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
- William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
- William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
- William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
- William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.
Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.